{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:25:04Z","timestamp":1773876304846,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003808","name":"Hospital Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003808","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jtct.2025.10.030","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:30:21Z","timestamp":1761870621000},"page":"201.e1-201.e16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Excellent Outcome of 1-Day Nonmyeloablative Salvage Regimen for Pediatric Patients with Graft Failure following Haploidentical Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4178-2777","authenticated-orcid":false,"given":"Wilson Y.K.","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela P.W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel K.L.","family":"Cheuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wing","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jtct.2025.10.030_bib0001","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41409-023-01953-1","article-title":"Activity of ex vivo graft and DLI engineering within the last decade increases, a survey from the EBMT Cellular Therapy & Immunobiology Working Party","volume":"58","author":"de Witte","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2025.10.030_bib0002","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41409-023-01976-8","article-title":"Graft engineering: how long can you wait, how low can you go, and pandemic readiness","volume":"58","author":"Nijssen","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2025.10.030_bib0003","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2014-03-563817","article-title":"HLA-haploidentical stem cell transplantation after removal of a\u00df+ T and B cells in children with nonmalignant disorders","volume":"124","author":"Bertaina","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.10.030_bib0004","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/bmt.2015.343","article-title":"TCR-alpha\/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia","volume":"51(5)","author":"Maschan","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2025.10.030_bib0005","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood-2017-04-779769","article-title":"Outcome of children with acute leukemia given HLA-haploidentical HSCT after a\u00df T-cell and B-cell depletion","volume":"130","author":"Locatelli","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2025.10.030_bib0006","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12823","article-title":"Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared with CD3-targeted T-cell depletion","volume":"20","author":"Triplett","year":"2018","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"10.1016\/j.jtct.2025.10.030_bib0007","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12185-021-03138-2","article-title":"Selective T-cell depletion targeting CD45RA as a novel approach for HLA-mismatched hematopoietic stem cell transplantation in pediatric nonmalignant hematological disease","volume":"114","author":"Gasior Kabat","year":"2021","journal-title":"Int J Hematol"},{"issue":"9327","key":"10.1016\/j.jtct.2025.10.030_bib0008","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0140-6736(02)09413-8","article-title":"Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1\/2 study","volume":"360","author":"Andr\u00e9-Schmutz","year":"2002","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jtct.2025.10.030_bib0009","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1200\/JCO.21.01755","article-title":"Naive T-cell depletion to prevent chronic graft-versus-host disease","volume":"40","author":"Bleakley","year":"2022","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jtct.2025.10.030_bib0010","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/leu.2015.75","article-title":"Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies","volume":"29","author":"Olsson","year":"2015","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.jtct.2025.10.030_bib0011","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/bmt.2011.158","article-title":"Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation","volume":"47","author":"Kanda","year":"2012","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.jtct.2025.10.030_bib0012","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1200\/JCO.2006.07.0953","article-title":"Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution","volume":"25","author":"Rizzieri","year":"2007","journal-title":"J Clin Oncol."},{"issue":"1","key":"10.1016\/j.jtct.2025.10.030_bib0013","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.bmt.1705882","article-title":"Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection","volume":"41","author":"Byrne","year":"2008","journal-title":"Bone Marrow Transplant."},{"issue":"11","key":"10.1016\/j.jtct.2025.10.030_bib0014","article-title":"One day preparative regimen for allogeneic non-myeloablative stem cell transplantation (NMSCT) using 3\u20135\/6 HLA matched related donors","volume":"102","author":"Goggins","year":"2003","journal-title":"Blood."},{"issue":"8","key":"10.1016\/j.jtct.2025.10.030_bib0015","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jtct.2021.04.007","volume":"27","author":"Kharfan-Dabaja","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"10.1016\/j.jtct.2025.10.030_bib0016","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41409-024-02251-0","article-title":"Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT","volume":"59","author":"Sureda","year":"2024","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2025.10.030_bib0017","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/bmt.2016.200","article-title":"Salvage haploidentical hematopoietic cell transplantation for graft rejection following a prior haploidentical allograft","volume":"52","author":"Epperla","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2025.10.030_bib0018","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant."},{"issue":"6","key":"10.1016\/j.jtct.2025.10.030_bib0019","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s41409-020-0803-y","article-title":"Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients","volume":"55","author":"Spyridonidis","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2025.10.030_bib0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41409-023-02139-5","article-title":"Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation","volume":"59","author":"Spyridonidis","year":"2024","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2025.10.030_bib0021","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant."},{"issue":"12","key":"10.1016\/j.jtct.2025.10.030_bib0022","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant."},{"issue":"3","key":"10.1016\/j.jtct.2025.10.030_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.jtct.2025.10.030_bib0024","unstructured":"Cancer Therapy Evaluation Program (CTEP). National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) Version 3.0 2003. Available at: https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/ctcaev3.pdf. Accessed 28 November, 2025."},{"issue":"suppl 1","key":"10.1016\/j.jtct.2025.10.030_bib0025","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1182\/blood-2023-184877","article-title":"Memory T cell donor lymphocyte infusion as a treatment for viral reactivations after pediatric haploidentical hematopoietic stem cell transplant","volume":"142","author":"Li","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.10.030_bib0026","article-title":"Novel CD62L depleted donor lymphocyte infusion with T-cell receptor alpha-beta depleted haploidentical hematopoietic stem cell transplantation in children","author":"Cheuk","year":"202589","journal-title":"Transpl Immunol."},{"issue":"1","key":"10.1016\/j.jtct.2025.10.030_bib0027","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/(SICI)1097-0320(19960315)26:1<8::AID-CYTO2>3.0.CO;2-E","article-title":"Age-and sex-related changes in lymphocyte subpopulations of healthy Asian subjects: from birth to adulthood","volume":"26","author":"Lee","year":"1996","journal-title":"Cytometry."},{"issue":"8","key":"10.1016\/j.jtct.2025.10.030_bib0028","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1038\/bcj.2013.39","article-title":"Risk-adapted donor lymphocyte infusion based on chimerism and donor source in pediatric leukemia","volume":"3","author":"Rujkijyanont","year":"2013","journal-title":"Blood Cancer J"},{"issue":"5","key":"10.1016\/j.jtct.2025.10.030_bib0029","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14278","article-title":"Successful haploidentical hematopoietic stem cell transplantation (HSCT) and durable engraftment by repeated donor lymphocyte infusions for a Chinese patient with transfusion-dependent hemoglobin (Hb) Hammersmith and massive splenomegaly","volume":"26","author":"Chan","year":"2022","journal-title":"Pediatr Transplant."},{"issue":"8","key":"10.1016\/j.jtct.2025.10.030_bib0030","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.bbmt.2010.02.013","article-title":"Second unrelated donor hematopoietic cell transplantation for primary graft failure","volume":"16","author":"Schriber","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2025.10.030_bib0031","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1182\/blood-2008-03-147041","article-title":"Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia","volume":"113","author":"Atsuta","year":"2009","journal-title":"Blood."},{"issue":"6","key":"10.1016\/j.jtct.2025.10.030_bib0032","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.bbmt.2010.09.009","article-title":"Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning","volume":"17","author":"Kanda","year":"2011","journal-title":"Biol Blood Marrow Transplant."},{"issue":"10","key":"10.1016\/j.jtct.2025.10.030_bib0033","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.bbmt.2011.02.001","article-title":"Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin","volume":"17","author":"Sauter","year":"2011","journal-title":"Biol Blood Marrow Transplant."},{"issue":"15","key":"10.1016\/j.jtct.2025.10.030_bib0034","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","article-title":"Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse","volume":"23","author":"Aversa","year":"2005","journal-title":"J Clin Oncol."},{"issue":"10","key":"10.1016\/j.jtct.2025.10.030_bib0035","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bbmt.2006.06.007","article-title":"Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning","volume":"12","author":"Ogawa","year":"2006","journal-title":"Biol Blood Marrow Transplant."},{"issue":"11","key":"10.1016\/j.jtct.2025.10.030_bib0036","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.bbmt.2007.08.003","article-title":"Allogeneic hematopoietic stem cell transplant using mismatched\/haploidentical donors","volume":"13","author":"Koh","year":"2007","journal-title":"Biol Blood Marrow Transplant."},{"issue":"5","key":"10.1016\/j.jtct.2025.10.030_bib0037","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s11912-010-0113-4","article-title":"Haploidentical transplantation for leukemia","volume":"12","author":"Kanda","year":"2010","journal-title":"Curr Oncol Rep."},{"issue":"3","key":"10.1016\/j.jtct.2025.10.030_bib0038","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1084\/jem.20040613","article-title":"Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA peptide tetramers","volume":"202","author":"Cobbold","year":"2005","journal-title":"J Exp Med."},{"issue":"9393","key":"10.1016\/j.jtct.2025.10.030_bib0039","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(03)14634-X","article-title":"Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines","volume":"362","author":"Peggs","year":"2003","journal-title":"Lancet."},{"issue":"6","key":"10.1016\/j.jtct.2025.10.030_bib0040","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood-2006-02-001909","article-title":"Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation","volume":"108","author":"Amrolia","year":"2006","journal-title":"Blood."},{"issue":"11","key":"10.1016\/j.jtct.2025.10.030_bib0041","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1097\/TP.0b013e3181bbf382","article-title":"Phase I study of high-stringency CD8 depletion of donor leukocyte infusions after allogeneic hematopoietic stem cell transplantation","volume":"88","author":"Orti","year":"2009","journal-title":"Transplantation."},{"issue":"22","key":"10.1016\/j.jtct.2025.10.030_bib0042","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1182\/blood.V114.22.512.512","article-title":"Haploidentical stem cell transplantation: high doses of alloreactie T-cell depleted donor lymphocytes administered post-transplant decrease infections and improve survival without causing severe GVHD","volume":"114","author":"Roy","year":"2009","journal-title":"Blood."}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725015337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725015337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T15:53:14Z","timestamp":1773849194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725015337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2666636725015337"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.10.030","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Excellent Outcome of 1-Day Nonmyeloablative Salvage Regimen for Pediatric Patients with Graft Failure following Haploidentical Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.10.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Transplantation and Cellular Therapy. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}